Summary of Discordant Cases of First PD Classification by CP and Volumetric Measures
| . | Segmented Volume . | Ellipsoid volume . | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | 40% threshold . | . | . | 30% threshold . | . | . | 40% threshold . | . | . | 50% threshold . | . | . |
| . | PD by volume but not CP . | PD by CP but not volume . | P-value . | PD by volume but not CP . | PD by CP but not volume . | P-value . | PD by volume but not CP . | PD by CP but not volume . | P-value . | PD by volume but not CP . | PD by CP but not volume . | P-value . |
| n | 5 | 13 | -- | 7 | 5 | -- | 9 | 3 | -- | 6 | 6 | -- |
| Survival from MRI(months) (median [Range]) | 3.0 (1–7) | 6.0 (1–25) | 0.011* | 5.0 (1–21) | 9.0 (2–25) | 0.30 | 7.0 (1–32) | 6.0 (6–18) | 0.81 | 7.4 (2–15) | 11.2 (6–25) | 0.13 |
| Cranial-caudal tumor growth# (increase from smallest prior) (median [Range]) | 37.5% (8.3% to 83.6%) | 15.5% (–7.0% to 22.9%) | 0.019* | 25.4% (1.3% to 83.6%) | 13.1% (–7.0% to 20.3%) | 0.106 | 34.7% (21.0% to 83.6%) | 3.4% (–7.0% to 20.5%) | 0.009* | 37.5% (22.4% to 83.6%) | 13.1% (–7.0% to 22.9%) | 0.005* |
| . | Segmented Volume . | Ellipsoid volume . | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | 40% threshold . | . | . | 30% threshold . | . | . | 40% threshold . | . | . | 50% threshold . | . | . |
| . | PD by volume but not CP . | PD by CP but not volume . | P-value . | PD by volume but not CP . | PD by CP but not volume . | P-value . | PD by volume but not CP . | PD by CP but not volume . | P-value . | PD by volume but not CP . | PD by CP but not volume . | P-value . |
| n | 5 | 13 | -- | 7 | 5 | -- | 9 | 3 | -- | 6 | 6 | -- |
| Survival from MRI(months) (median [Range]) | 3.0 (1–7) | 6.0 (1–25) | 0.011* | 5.0 (1–21) | 9.0 (2–25) | 0.30 | 7.0 (1–32) | 6.0 (6–18) | 0.81 | 7.4 (2–15) | 11.2 (6–25) | 0.13 |
| Cranial-caudal tumor growth# (increase from smallest prior) (median [Range]) | 37.5% (8.3% to 83.6%) | 15.5% (–7.0% to 22.9%) | 0.019* | 25.4% (1.3% to 83.6%) | 13.1% (–7.0% to 20.3%) | 0.106 | 34.7% (21.0% to 83.6%) | 3.4% (–7.0% to 20.5%) | 0.009* | 37.5% (22.4% to 83.6%) | 13.1% (–7.0% to 22.9%) | 0.005* |
Statistically significant P-values (<.05) are designated by *.
# Excludes two cases of pseudoprogression by volume.
Summary of Discordant Cases of First PD Classification by CP and Volumetric Measures
| . | Segmented Volume . | Ellipsoid volume . | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | 40% threshold . | . | . | 30% threshold . | . | . | 40% threshold . | . | . | 50% threshold . | . | . |
| . | PD by volume but not CP . | PD by CP but not volume . | P-value . | PD by volume but not CP . | PD by CP but not volume . | P-value . | PD by volume but not CP . | PD by CP but not volume . | P-value . | PD by volume but not CP . | PD by CP but not volume . | P-value . |
| n | 5 | 13 | -- | 7 | 5 | -- | 9 | 3 | -- | 6 | 6 | -- |
| Survival from MRI(months) (median [Range]) | 3.0 (1–7) | 6.0 (1–25) | 0.011* | 5.0 (1–21) | 9.0 (2–25) | 0.30 | 7.0 (1–32) | 6.0 (6–18) | 0.81 | 7.4 (2–15) | 11.2 (6–25) | 0.13 |
| Cranial-caudal tumor growth# (increase from smallest prior) (median [Range]) | 37.5% (8.3% to 83.6%) | 15.5% (–7.0% to 22.9%) | 0.019* | 25.4% (1.3% to 83.6%) | 13.1% (–7.0% to 20.3%) | 0.106 | 34.7% (21.0% to 83.6%) | 3.4% (–7.0% to 20.5%) | 0.009* | 37.5% (22.4% to 83.6%) | 13.1% (–7.0% to 22.9%) | 0.005* |
| . | Segmented Volume . | Ellipsoid volume . | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | 40% threshold . | . | . | 30% threshold . | . | . | 40% threshold . | . | . | 50% threshold . | . | . |
| . | PD by volume but not CP . | PD by CP but not volume . | P-value . | PD by volume but not CP . | PD by CP but not volume . | P-value . | PD by volume but not CP . | PD by CP but not volume . | P-value . | PD by volume but not CP . | PD by CP but not volume . | P-value . |
| n | 5 | 13 | -- | 7 | 5 | -- | 9 | 3 | -- | 6 | 6 | -- |
| Survival from MRI(months) (median [Range]) | 3.0 (1–7) | 6.0 (1–25) | 0.011* | 5.0 (1–21) | 9.0 (2–25) | 0.30 | 7.0 (1–32) | 6.0 (6–18) | 0.81 | 7.4 (2–15) | 11.2 (6–25) | 0.13 |
| Cranial-caudal tumor growth# (increase from smallest prior) (median [Range]) | 37.5% (8.3% to 83.6%) | 15.5% (–7.0% to 22.9%) | 0.019* | 25.4% (1.3% to 83.6%) | 13.1% (–7.0% to 20.3%) | 0.106 | 34.7% (21.0% to 83.6%) | 3.4% (–7.0% to 20.5%) | 0.009* | 37.5% (22.4% to 83.6%) | 13.1% (–7.0% to 22.9%) | 0.005* |
Statistically significant P-values (<.05) are designated by *.
# Excludes two cases of pseudoprogression by volume.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
